KDM6A and lung adenocarcinoma: We again observed significantly higher of KDM6A-pSer829 levels in tumors than in adjacent tissues in a cohort of Lung Squamous cancer, Lung Adenocarcinoma, and Liver Hepatocyte cancer patients (Fig. 1C, D).